| CGEN Snapshot | |
|---|---|
| Compugen Ltd., a clinical-stage therapeutic discovery and development company, is engaged in the research, development, and commercialization of therapeutic candidates and products in Israel, the United States, and Europe. The company is headquartered in Holon, Israel. | |
| VALUATION DATA | |
| Market Capitalization | $168,317,000 | Price to Sales | 0.00 |
| Earnings per Share | $-0.2100 |
| PE Ratio | None |
| PRICE DATA | |
| Most Recent Close | $1.9000 |
| 52 Week High | $6.04 |
| 52 Week Low | $2.909 |
| 50-Day Moving Average | $4.538 |
| 200-Day Moving Average | $-12.13 |
| All data are from Alpha Vantage as of today. For more infomation on CGEN see Stock Dividend, Valuation, Price and Financial Data for Investors | |
Custom Search